Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan | Zendy

Mitsushige Sugimoto | Zendy; Takahiro Uotani | Zendy; Hitomi Ichikawa | Zendy; Akira Andoh | Zendy; Takahisa Furuta | Zendy

Open Access

Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with <b><i>Helicobacter pylori</i></b> in Japan

Author(s) -

Mitsushige Sugimoto,

Takahiro Uotani,

Hitomi Ichikawa,

Akira Andoh,

Takahisa Furuta

Publication year - 2016

Publication title -

digestion

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.882

H-Index - 75

eISSN - 1421-9867

pISSN - 0012-2823

DOI - 10.1159/000441741

Subject(s) - helicobacter pylori , gerd , medicine , gastroenterology , reflux , population , reflux esophagitis , disease , environmental health

The prevalence of gastroesophageal reflux disease (GERD) has increased in Japan since the end of the 20th century due to changes in environmental factors, such as a decreased infection rate of Helicobacter pylori and increased ability of acid secretion in the Japanese population. In 2013, the Japanese health insurance system started to cover eradication treatment for all patients infected with H. pylori to prevent gastric cancer, suggesting we may soon be able to completely eradicate this infection in Japan. Re-clarification of the clinical characteristics of GERD in Japan is therefore required in time covering the eradication for all patients infected with H. pylori.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research